Pyeongchang, South Korea

Hyuk Joon Kwon

This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyuk Joon Kwon. Retrieved from https://idiyas.com/inventor/hyuk-joon-kwon-uw7usv7n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyuk Joon Kwon: Innovator in Influenza Vaccine Development

Introduction

Hyuk Joon Kwon is a prominent inventor based in Pyeongchang-gun, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines for influenza viruses. His innovative work has the potential to enhance public health and safety.

Latest Patents

Hyuk Joon Kwon holds a patent for a recombinant influenza virus, specifically the H5N6 strain. The patent describes a composition for preparing the virus and a vaccine composition containing it. This invention relates to a mammalian non-pathogenic, highly productive-in-embryonated-egg, heat-resistant, and attenuated clade 2.3.4.4c H5N6 recombinant influenza A virus. The vaccine composition includes the recombinant influenza virus and an artificial H5 gene as active ingredients.

Career Highlights

Hyuk Joon Kwon is affiliated with Seoul National University, where he conducts research and development in the field of infectious diseases. His work focuses on creating effective vaccines that can combat various strains of influenza, thereby contributing to global health initiatives.

Collaborations

Hyuk Joon Kwon collaborates with notable colleagues, including Se Hee An and Seung Min Hong. Their combined expertise enhances the research efforts and innovation in vaccine development.

Conclusion

Hyuk Joon Kwon's contributions to the field of influenza vaccine development are noteworthy. His innovative patent and collaboration with esteemed colleagues position him as a key figure in advancing public health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…